SHAREHOLDERS' EQUITY (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Jul. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average basic common shares (in shares)	13,824,000	13,441,000
Effect of stock options (in shares)	0	0
Effect of dilutive share awards (in shares)	313,000	0
Weighted average diluted common shares (in shares)	14,137,000	13,441,000
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)		200,000
Aggregate shares to be sold, maximum			$ 50.0
Common stock repurchases
Purchased shares of common stock under stock repurchase program (in shares)	0	0
Remaining authorized repurchase amount	$ 96.7
2025 Convertible Notes
Additional disclosure
Stated interest rate	0.50%	0.50%
Option
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	800,000	900,000
RSUs
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)	0	0
Convertible Debt
Additional disclosure
Antidilutive securities excluded from computation of earnings per share (in shares)		300,000